At5g44360 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01 M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
At5g44360 antibody; K9L2.15Berberine bridge enzyme-like 23 antibody; AtBBE-like 23 antibody; EC 1.1.1.- antibody
Target Names
At5g44360
Uniprot No.

Target Background

Database Links

KEGG: ath:AT5G44360

STRING: 3702.AT5G44360.1

UniGene: At.28010

Protein Families
Oxygen-dependent FAD-linked oxidoreductase family
Subcellular Location
Secreted, cell wall.
Tissue Specificity
Accumulates in cell walls of etiolated hypocotyls.

Q&A

What criteria should I use when selecting an antibody against At5g44360 protein?

When selecting an antibody for At5g44360 protein detection, consider the following methodological criteria:

  • Application compatibility: Determine whether the antibody has been validated for your specific application (Western blot, immunoprecipitation, or immunofluorescence).

  • Antibody type: Consider recombinant antibodies over monoclonal or polyclonal options as data shows recombinant antibodies generally perform better across applications .

  • Epitope location: Confirm the antibody targets a unique, accessible epitope in the At5g44360 protein structure.

  • Validation evidence: Request comprehensive validation data including positive and negative controls, especially knockout-validated antibodies when available.

  • Literature citations: Review publications that have successfully used the antibody for similar applications in Arabidopsis thaliana research.

Research indicates that approximately 50% of commercial antibodies fail in one or more applications, making thorough validation critical to experimental success .

How can I validate an At5g44360 antibody before using it in my experiments?

Antibody validation should follow a systematic approach:

  • Perform western blot analysis using:

    • Wild-type Arabidopsis samples (positive control)

    • At5g44360 knockout/knockdown lines (negative control)

    • Recombinant At5g44360 protein (if available)

  • Test for cross-reactivity with similar proteins by:

    • Using samples with overexpressed homologous proteins

    • Comparing band patterns against predicted molecular weights

    • Performing peptide competition assays

  • Validate in your specific application using standardized protocols agreed upon by the scientific community .

  • Document all validation steps methodically for publication requirements.

According to antibody validation studies, success in immunofluorescence is the best predictor of performance in Western blot and immunoprecipitation applications .

What are the most reliable methods to quantify At5g44360 antibody specificity?

For quantitative assessment of antibody specificity:

  • Signal-to-noise ratio analysis: Calculate the ratio between specific signal intensity and background.

  • Cross-reactivity assessment using ELISA against a panel of similar proteins.

  • Quantitative Western blot analysis with increasing protein concentrations to establish a standard curve.

  • Knockout validation approach, measuring signal reduction in genetic knockouts/knockdowns.

  • Peptide array analysis to map exact epitope binding.

Document quantification using:

Validation MethodSpecificity MetricsAcceptance Criteria
Western BlotBand intensity ratio (specific/non-specific)>10:1 ratio
ELISACross-reactivity percentage<5% with related proteins
ImmunofluorescenceColocalization coefficient>0.8 with known markers
Knockout ValidationSignal reduction percentage>90% signal reduction

How should I design experiments to study At5g44360 protein expression patterns?

Design a comprehensive experimental approach:

  • Define clear variables:

    • Independent variable: Experimental conditions (e.g., developmental stages, stress treatments)

    • Dependent variable: At5g44360 protein levels/localization

    • Confounding variables to control: Growth conditions, tissue types, extraction methods

  • Establish appropriate controls:

    • Positive controls: Samples known to express At5g44360

    • Negative controls: Knockout lines or pre-immune serum

    • Loading controls: Constitutively expressed proteins

  • Implement a time-course design to capture dynamic expression patterns.

  • Use biological replicates (n≥3) and technical replicates to ensure statistical validity.

  • Plan complementary approaches (protein and transcript analysis) to correlate protein expression with gene activity .

This systematic approach aligns with experimental design principles that emphasize variable control and hypothesis testing .

What are the optimal conditions for immunoprecipitation of At5g44360 protein complexes?

For successful immunoprecipitation of At5g44360 protein complexes:

  • Lysis buffer optimization:

    • Test multiple buffer compositions (RIPA, NP-40, Triton X-100)

    • Adjust salt concentration (150-500 mM NaCl)

    • Include appropriate protease and phosphatase inhibitors

    • Consider native vs. denaturing conditions based on complex stability

  • Antibody coupling approach:

    • Direct coupling to beads for cleaner results

    • Pre-clearing lysates to reduce non-specific binding

    • Determining optimal antibody:lysate ratio through titration

  • Washing stringency balance:

    • Start with low-stringency washes and increase gradually

    • Monitor target protein retention vs. background reduction

Based on antibody performance studies, approximately 75% of proteins can be successfully immunoprecipitated using at least one high-performing antibody , making optimization critical for capturing low-abundance plant proteins like At5g44360.

How can I quantitatively analyze At5g44360 protein levels in different plant tissues?

Implement multiple quantitative approaches:

  • Quantitative Western blot analysis:

    • Use infrared fluorescence detection systems for expanded dynamic range

    • Include standard curves with recombinant protein

    • Normalize to total protein (Ponceau S) rather than single housekeeping proteins

    • Apply densitometry analysis with appropriate software

  • ELISA-based quantification:

    • Develop a sandwich ELISA with two antibodies recognizing different At5g44360 epitopes

    • Include standard curves with purified protein

    • Determine limits of detection and quantification

  • Sample preparation standardization:

    • Standardize tissue collection (time, developmental stage)

    • Optimize protein extraction to ensure complete solubilization

    • Measure total protein content before analysis

Research shows that quantitative analysis methodologies must be carefully validated to ensure accuracy across different tissue types and experimental conditions .

How can computational approaches improve At5g44360 antibody design and specificity?

Advanced computational strategies include:

  • Epitope prediction and analysis:

    • Use machine learning algorithms to identify unique, accessible epitopes

    • Apply structural bioinformatics to select epitopes in stable protein regions

    • Model epitope-antibody interactions using molecular dynamics simulations

  • QTY code design implementation:

    • Apply the QTY code to systematically replace hydrophobic residues with hydrophilic alternatives

    • Model changes to antibody structure and stability before production

    • Predict reduction in aggregation propensity

  • AlphaFold2 integration:

    • Utilize protein structural predictions to identify accessible epitopes

    • Model antibody-antigen interactions in silico

    • Design stabilizing modifications based on structural insights

Research demonstrates that QTY code design can significantly decrease aggregation propensity while maintaining antigen-binding affinity and structural stability , offering significant advantages for plant protein antibodies that may have challenging solubility profiles.

What approaches can resolve discrepancies between antibody-based detection and transcript analysis of At5g44360?

To address data inconsistencies:

  • Targeted validation experiments:

    • Compare protein half-life across tissues using cycloheximide chase assays

    • Analyze post-transcriptional regulation using reporter constructs

    • Investigate post-translational modifications affecting antibody recognition

  • Correlation analysis:

    • Perform time-course experiments capturing both transcript and protein levels

    • Calculate time-lag relationships between mRNA and protein changes

    • Derive mathematical models describing the relationship

  • Multi-antibody validation:

    • Test multiple antibodies targeting different protein regions

    • Combine results from different detection methods (WB, ELISA, IF)

    • Create a consensus profile based on multiple detection approaches

  • Targeted mass spectrometry:

    • Apply parallel reaction monitoring to directly quantify At5g44360 peptides

    • Compare antibody-based and MS-based quantification results

    • Identify potential modifications affecting antibody binding

Studies indicate that protein-transcript correlations can be complex due to differences in half-life, translational efficiency, and post-translational regulation .

How can I conduct multiplexed analysis of At5g44360 with interacting proteins?

For advanced co-expression and interaction studies:

  • Multiplexed immunofluorescence:

    • Select antibodies raised in different host species

    • Use directly labeled primary antibodies to avoid cross-reactivity

    • Employ spectral unmixing for closely overlapping fluorophores

    • Conduct sequential staining for technically challenging combinations

  • Proximity ligation assays:

    • Optimize probe and antibody combinations for maximum sensitivity

    • Include appropriate distance controls to validate interactions

    • Quantify interaction signals using automated image analysis

  • Co-immunoprecipitation optimization:

    • Test different lysis conditions to preserve interactions

    • Consider crosslinking to stabilize transient interactions

    • Use mass spectrometry to identify novel interaction partners

  • Bimolecular Fluorescence Complementation:

    • Design appropriate fusion constructs for At5g44360 and suspected partners

    • Include appropriate controls to validate specificity

    • Optimize expression levels to reduce artifacts

Research indicates that evidence from multiple independent methodologies significantly strengthens interaction findings and reduces the possibility of method-specific artifacts .

What are the most common causes of false results when using At5g44360 antibodies?

Key sources of error include:

  • Antibody-related factors:

    • Cross-reactivity with related plant proteins

    • Batch-to-batch variability affecting performance

    • Non-specific binding to abundant proteins

    • Inadequate validation before experimental use

  • Technical issues:

    • Incomplete protein extraction from plant tissues

    • Inefficient protein transfer during Western blotting

    • Epitope masking by protein modifications or interactions

    • Fixation artifacts in immunofluorescence studies

  • Experimental design problems:

    • Inadequate controls (positive, negative, loading)

    • Sample degradation affecting epitope integrity

    • Buffer incompatibilities affecting antibody binding

Research shows that more than 50% of antibodies fail in one or more applications , making thorough validation and appropriate controls essential for reliable results.

How can I overcome weak or absent signal when detecting At5g44360 protein?

Systematic optimization approaches include:

  • Sample preparation enhancement:

    • Optimize extraction buffers for plant tissue-specific challenges

    • Concentrate proteins using immunoprecipitation before detection

    • Test different extraction methods for membrane-associated proteins

  • Signal amplification strategies:

    • Implement tyramide signal amplification for immunofluorescence

    • Use high-sensitivity chemiluminescent substrates for Western blots

    • Increase antibody concentration or incubation time (with appropriate controls)

  • Protocol optimization:

    • Test different blocking agents to reduce background

    • Optimize antibody dilution through titration experiments

    • Adjust incubation temperature and duration

    • Consider antigen retrieval methods for fixed samples

Creating a systematic optimization matrix and testing variables individually helps identify the specific limitations in your experimental system .

How should I interpret conflicting results from different antibodies targeting At5g44360?

To resolve contradictory findings:

  • Conduct a comprehensive antibody assessment:

    • Compare epitope locations for each antibody

    • Verify validation methods used for each antibody

    • Assess performance in identical samples under standardized conditions

  • Consider biological explanations:

    • Protein isoforms recognized differentially by antibodies

    • Post-translational modifications masking specific epitopes

    • Protein complexes blocking antibody access to certain regions

  • Implement confirmatory approaches:

    • Use genetic approaches (knockout/knockdown validation)

    • Apply orthogonal detection methods (mass spectrometry)

    • Generate new antibodies against well-characterized epitopes

  • Analyze methodological differences:

    • Sample preparation variations

    • Detection system sensitivity differences

    • Protocol variations affecting epitope accessibility

Create a detailed comparison table documenting all variables:

AntibodyEpitope LocationValidation MethodDetection SystemResultsPotential Limitations
Ab1N-terminusWestern blotChemiluminescencePositiveMay detect isoforms
Ab2Middle domainKnockout cellsFluorescenceNegativeEpitope may be masked
Ab3C-terminusMass spectrometryColorimetricPositiveLower sensitivity

How can I apply NGS data analysis approaches to study At5g44360 antibody specificity?

Next-generation sequencing can enhance antibody research through:

  • Epitope mapping via phage display sequencing:

    • Generate phage libraries displaying peptides from At5g44360

    • Perform selection rounds with the antibody of interest

    • Sequence enriched phages to identify binding epitopes

    • Analyze sequence convergence to define critical binding residues

  • NGS analysis workflow implementation:

    • Quality control and trimming of raw sequence data

    • Assembly and merging of paired-end data

    • Annotation and comparison of sequences

    • Clustering of annotated sequences to identify patterns

  • Visualizing antibody binding patterns:

    • Generate heat maps showing epitope enrichment

    • Utilize sequence viewer tools to inspect binding regions

    • Apply amino acid variability plots to identify critical residues

  • Cross-reactivity assessment:

    • Compare binding patterns with homologous proteins

    • Identify shared epitope regions across protein families

    • Predict potential cross-reactivity based on sequence similarity

NGS-based approaches can analyze millions of antibody-epitope interactions efficiently, providing comprehensive specificity profiles beyond traditional methods .

What are the emerging technologies for studying At5g44360 protein interactions using antibody-based approaches?

Cutting-edge methodologies include:

  • Proximity-dependent biotinylation (BioID/TurboID):

    • Generate fusion constructs with At5g44360 and biotin ligase

    • Express in Arabidopsis using appropriate promoters

    • Purify biotinylated proteins using streptavidin

    • Identify interaction partners via mass spectrometry

    • Validate key interactions with co-immunoprecipitation

  • Single-molecule imaging:

    • Utilize directly labeled antibody fragments for live-cell imaging

    • Track individual protein molecules to determine dynamics

    • Measure protein-protein interaction kinetics in vivo

    • Correlate localization with function in different cellular compartments

  • Antibody-guided CRISPR techniques:

    • Target CRISPR machinery to specific genomic locations using antibodies

    • Modify chromatin at At5g44360 binding sites

    • Study functional consequences of targeted modifications

  • Spatial transcriptomics integration:

    • Combine antibody detection with spatial transcriptomics

    • Correlate protein localization with local transcriptional changes

    • Map protein-DNA interactions across tissues and conditions

These approaches represent the frontier of plant molecular biology research, enabling precise spatial and temporal analysis of At5g44360 function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.